Obesity and cancer - Mechanisms underlying tumour progression and recurrence

Jiyoung Park, Thomas S. Morley, Min Kim, Deborah J. Clegg, Philipp E. Scherer

Research output: Contribution to journalArticle

211 Citations (Scopus)

Abstract

Over the past several years, the field of cancer research has directed increased interest towards subsets of obesity-associated tumours, which include mammary, renal, oesophageal, gastrointestinal and reproductive cancers in both men and women. The increased risk of breast cancer that is associated with obesity has been widely reported; this has drawn much attention and as such, warrants investigation of the key mechanisms that link the obese state with cancer aetiology. For instance, the obese setting provides a unique adipose tissue microenvironment with concomitant systemic endocrine alterations that favour both tumour initiation and progression. Major metabolic differences exist within tumours that distinguish them from non-transformed healthy tissues. Importantly, considerable metabolic differences are induced by tumour cells in the stromal vascular fraction that surrounds them. The precise mechanisms that underlie the association of obesity with cancer and the accompanying metabolic changes that occur in the surrounding microenvironment remain elusive. Nonetheless, specific therapeutic agents designed for patients with obesity who develop tumours are clearly needed. This Review discusses recent advances in understanding the contributions of obesity to cancer and their implications for tumour treatment.

Original languageEnglish (US)
Pages (from-to)455-465
Number of pages11
JournalNature Reviews Endocrinology
Volume10
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Obesity
Recurrence
Neoplasms
Gastrointestinal Neoplasms
Proxy
Stromal Cells
Blood Vessels
Adipose Tissue
Breast
Breast Neoplasms
Kidney
Therapeutics
Research

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Obesity and cancer - Mechanisms underlying tumour progression and recurrence. / Park, Jiyoung; Morley, Thomas S.; Kim, Min; Clegg, Deborah J.; Scherer, Philipp E.

In: Nature Reviews Endocrinology, Vol. 10, No. 8, 2014, p. 455-465.

Research output: Contribution to journalArticle

Park, Jiyoung ; Morley, Thomas S. ; Kim, Min ; Clegg, Deborah J. ; Scherer, Philipp E. / Obesity and cancer - Mechanisms underlying tumour progression and recurrence. In: Nature Reviews Endocrinology. 2014 ; Vol. 10, No. 8. pp. 455-465.
@article{0a22334a893b40f8b89514fcff64442c,
title = "Obesity and cancer - Mechanisms underlying tumour progression and recurrence",
abstract = "Over the past several years, the field of cancer research has directed increased interest towards subsets of obesity-associated tumours, which include mammary, renal, oesophageal, gastrointestinal and reproductive cancers in both men and women. The increased risk of breast cancer that is associated with obesity has been widely reported; this has drawn much attention and as such, warrants investigation of the key mechanisms that link the obese state with cancer aetiology. For instance, the obese setting provides a unique adipose tissue microenvironment with concomitant systemic endocrine alterations that favour both tumour initiation and progression. Major metabolic differences exist within tumours that distinguish them from non-transformed healthy tissues. Importantly, considerable metabolic differences are induced by tumour cells in the stromal vascular fraction that surrounds them. The precise mechanisms that underlie the association of obesity with cancer and the accompanying metabolic changes that occur in the surrounding microenvironment remain elusive. Nonetheless, specific therapeutic agents designed for patients with obesity who develop tumours are clearly needed. This Review discusses recent advances in understanding the contributions of obesity to cancer and their implications for tumour treatment.",
author = "Jiyoung Park and Morley, {Thomas S.} and Min Kim and Clegg, {Deborah J.} and Scherer, {Philipp E.}",
year = "2014",
doi = "10.1038/nrendo.2014.94",
language = "English (US)",
volume = "10",
pages = "455--465",
journal = "Nature Reviews Endocrinology",
issn = "1759-5029",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Obesity and cancer - Mechanisms underlying tumour progression and recurrence

AU - Park, Jiyoung

AU - Morley, Thomas S.

AU - Kim, Min

AU - Clegg, Deborah J.

AU - Scherer, Philipp E.

PY - 2014

Y1 - 2014

N2 - Over the past several years, the field of cancer research has directed increased interest towards subsets of obesity-associated tumours, which include mammary, renal, oesophageal, gastrointestinal and reproductive cancers in both men and women. The increased risk of breast cancer that is associated with obesity has been widely reported; this has drawn much attention and as such, warrants investigation of the key mechanisms that link the obese state with cancer aetiology. For instance, the obese setting provides a unique adipose tissue microenvironment with concomitant systemic endocrine alterations that favour both tumour initiation and progression. Major metabolic differences exist within tumours that distinguish them from non-transformed healthy tissues. Importantly, considerable metabolic differences are induced by tumour cells in the stromal vascular fraction that surrounds them. The precise mechanisms that underlie the association of obesity with cancer and the accompanying metabolic changes that occur in the surrounding microenvironment remain elusive. Nonetheless, specific therapeutic agents designed for patients with obesity who develop tumours are clearly needed. This Review discusses recent advances in understanding the contributions of obesity to cancer and their implications for tumour treatment.

AB - Over the past several years, the field of cancer research has directed increased interest towards subsets of obesity-associated tumours, which include mammary, renal, oesophageal, gastrointestinal and reproductive cancers in both men and women. The increased risk of breast cancer that is associated with obesity has been widely reported; this has drawn much attention and as such, warrants investigation of the key mechanisms that link the obese state with cancer aetiology. For instance, the obese setting provides a unique adipose tissue microenvironment with concomitant systemic endocrine alterations that favour both tumour initiation and progression. Major metabolic differences exist within tumours that distinguish them from non-transformed healthy tissues. Importantly, considerable metabolic differences are induced by tumour cells in the stromal vascular fraction that surrounds them. The precise mechanisms that underlie the association of obesity with cancer and the accompanying metabolic changes that occur in the surrounding microenvironment remain elusive. Nonetheless, specific therapeutic agents designed for patients with obesity who develop tumours are clearly needed. This Review discusses recent advances in understanding the contributions of obesity to cancer and their implications for tumour treatment.

UR - http://www.scopus.com/inward/record.url?scp=84904722547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904722547&partnerID=8YFLogxK

U2 - 10.1038/nrendo.2014.94

DO - 10.1038/nrendo.2014.94

M3 - Article

C2 - 24935119

AN - SCOPUS:84904722547

VL - 10

SP - 455

EP - 465

JO - Nature Reviews Endocrinology

JF - Nature Reviews Endocrinology

SN - 1759-5029

IS - 8

ER -